Editas Medicine Inc (EDIT)
1.34
-0.11
(-7.59%)
USD |
NASDAQ |
Jan 08, 16:00
1.345
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Research and Development Expense (Annual): 177.65M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Ionis Pharmaceuticals Inc | 899.62M |
Johnson & Johnson | 15.08B |
Pfizer Inc | 10.68B |
Revvity Inc | 216.58M |
Kodiak Sciences Inc | 206.30M |